(Q44925191)

7 December 2017

Outcome of coronavirus-associated severe acute respiratory syndrome using a standard treatment protocol (English)

1 reference

7 December 2017

1 reference

Arthur Chun-Wing Lau

1

1 reference

7 December 2017

Loletta Kit-Ying So

2

1 reference

7 December 2017

Flora Pui-Ling Miu

3

1 reference

7 December 2017

Raymond Wai-Hung Yung

4

1 reference

7 December 2017

Edwin Poon

5

1 reference

7 December 2017

Thomas Man-Tat Cheung

6

1 reference

7 December 2017

Loretta Yin-Chun Yam

7

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

7 December 2017

1 reference

7 December 2017

9

1 reference

7 December 2017

173-183

1 reference

7 December 2017

2

1 reference

A cluster of cases of severe acute respiratory syndrome in Hong Kong.

7 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2004.00588.X

A novel coronavirus associated with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2004.00588.X

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2004.00588.X

Coronavirus as a possible cause of severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2004.00588.X

A major outbreak of severe acute respiratory syndrome in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2004.00588.X

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2004.00588.X

Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2004.00588.X

Severe Acute Respiratory Syndrome: Clinical Outcome and Prognostic Correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2004.00588.X

Development of a standard treatment protocol for severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2004.00588.X

Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2004.00588.X

A note on the use of the intraclass correlation coefficient in the evaluation of agreement between two methods of measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2004.00588.X

Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2004.00588.X

Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2004.00588.X

Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2004.00588.X

Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2004.00588.X

Management of severe acute respiratory syndrome: the Hong Kong University experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2004.00588.X

High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2004.00588.X

Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2004.00588.X

The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2004.00588.X

Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2004.00588.X

Coronavirus pneumonia following autologous bone marrow transplantation for breast cancer

21 January 2018

1 reference

12 December 2020

Cytokines IL-1beta, IL-6, and TNF-alpha enhance in vitro growth of bacteria

1 reference

12 December 2020

Severe acute respiratory syndrome treatment: present status and future strategy

1 reference

12 December 2020

Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study.

1 reference

12 December 2020

Physiological Functions of Glucocorticoids in Stress and Their Relation to Pharmacological Actions*

1 reference

12 December 2020

Adjuvant corticosteroid therapy for Pneumocystis carinii pneumonia in AIDS patients

1 reference

12 December 2020

Measles pneumonia. Treatment of a near-fatal case with corticosteroids and vitamin A.

1 reference

12 December 2020

Corticosteroids in life-threatening varicella pneumonia

1 reference

12 December 2020

Treatment of severe acute respiratory syndrome with convalescent plasma

1 reference

12 December 2020

A case of mumps pneumonia complicated with acute respiratory failure

1 reference

12 December 2020

Potentiation of butylated-hydroxytoluene-induced acute lung damage by oxygen. Effects of prednisolone and indomethacin.

1 reference

12 December 2020

Effect of corticosteroids on IL1 beta and TNF alpha release by alveolar macrophages from patients with AIDS and Pneumocystis carinii pneumonia

1 reference

12 December 2020

Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response.

1 reference

12 December 2020

10.1111/J.1440-1843.2004.00588.X

Identifiers

DOI

1 reference

7 December 2017

0 references

1 reference